SyntecBio’s AI Digital Biotech Day 2025
Seoul, South Korea (June 21, 2025) — This fall, SyntecBio inc will convene more than 500 of the world’s brightest minds in biotechnology and artificial intelligence for AI Digital Biotech Day 2025, scheduled on September 12 at the COEX Conference Center in Seoul. Through both in-person sessions and a global livestream, the summit aims to chart a course for the next wave of innovation in drug discovery, synthetic biology and digital therapeutics.
From the opening keynote to the final networking lounge, participants will explore how machine learning can shrink drug development timelines by pinpointing targets with unprecedented speed, and how automated biofoundries are ushering in an era of “Synthetic Biology 2.0.” Industry leaders will also spotlight cutting-edge digital therapeutics platforms that monitor patient health in real time, personalize treatment regimens and amplify engagement outside the clinic.
“We’re standing at the intersection of data and molecules,” reflected Dr. Elena Voss, SyntecBio’s CTO. “By gathering AI experts, biotech entrepreneurs and healthcare visionaries under one roof, we’re accelerating the translation of algorithms into life-saving therapies.”
Spotlighted Sessions & Speakers
- AI-Guided Molecular Design in Oncology
Dr. Hiroshi Tanaka, CEO of GenMind AI Japan, will unveil how deep learning models are unveiling novel anti-cancer compounds months ahead of traditional screens. - From Design to Deployment: Engineering Smarter Microbes
Prof. Sarah Kim of MIT’s Center for Synthetic Biology will share breakthroughs in programming microbial “factories” for sustainable biofuel and bioplastic production. - Funding the Next Frontier in AI Biotech
Dr. Marco Rizzi, Venture Partner at Helix Capital, will dissect emerging investment trends that are fueling AI-driven startups and shaping the venture landscape.
Beyond these marquee presentations, attendees can pitch their own AI-biotech ventures to a panel of investors, debate the ethics and regulation of AI in healthcare, and forge global partnerships in dedicated collaboration lounges.
A Global Hub for Biotech Innovation
Since its founding in 2018, SyntecBio has grown from a Seoul-based startup into an international powerhouse, with research hubs in Boston and Singapore. The company’s AI-first approach has already produced multiple precision-medicine pipelines and scalable biomanufacturing processes that big pharma and agile startups alike are adopting.
With AI Digital Biotech Day 2025, SyntecBio seeks not only to showcase its own innovations but also to build a community capable of tackling the world’s most complex health challenges—from chronic diseases to pandemic preparedness.
Registration is now open at www.syntecbio.com/Media interested in covering the event can contact:
